Sunshine Biopharma Inc. (SBFM) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $36.31M | +4.1% |
| 2024 | $34.87M | +44.7% |
| 2023 | $24.09M | +454.4% |
| 2022 | $4.35M | +1802.4% |
| 2021 | $228.4K | +219.9% |
| 2020 | $71.4K | +238.1% |
| 2019 | $21.1K | — |
| 2018 | $0 | — |
| 2017 | $0 | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $36.31M | +4.1% |
| 2024 | $34.87M | +44.7% |
| 2023 | $24.09M | +454.4% |
| 2022 | $4.35M | +1802.4% |
| 2021 | $228.4K | +219.9% |
| 2020 | $71.4K | +238.1% |
| 2019 | $21.1K | — |
| 2018 | $0 | — |
| 2017 | $0 | — |